Mats Wahlstrom - Jun 12, 2025 Form 4 Insider Report for TriSalus Life Sciences, Inc. (TLSI)

Role
Director
Signature
/s/ Mary Szela, Attorney-in-Fact
Stock symbol
TLSI
Transactions as of
Jun 12, 2025
Transactions value $
$0
Form type
4
Date filed
6/27/2025, 04:12 PM
Previous filing
May 28, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Wahlstrom Mats Director 6272 W. 91ST AVENUE, WESTMINSTER /s/ Mary Szela, Attorney-in-Fact 2025-06-27 0001459154

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TLSI Director Stock Option (right to buy) Award $0 +15K +8.07% $0.00 201K Jun 12, 2025 Common Stock 15K $5.50 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option shall fully vest on the one-year anniversary of the grant date of June 12, 2025, provided that the shares subject to the option will in any case be fully vested on the date of the Issuer's next annual stockholder meeting, subject to the Reporting Person's continued service with the Issuer.